Organogenesis clinical trials

The registry lists 36 studies whose lead sponsor is Organogenesis or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 21, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

• 36studies on the registry
• 2open to participants now

Studies

Recruiting first, then most recently updated. Showing 36 of 36.

• Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)RecruitingNCT07510412Not applicable
• A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot UlcersRecruitingNCT06618612Not applicable
• A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the KneeCompletedNCT06000410Phase 3
• Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the KneeCompletedNCT04636229Phase 3
• PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.TerminatedNCT03502824Not applicable
• Clinical Study Of Affinity Versus SOC In The Management Of VLUsStatus unknownNCT04901013Not applicable
• Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot UlcersStatus unknownNCT03855514Not applicable
• Study of Nucel for One and Two Level Lumbar Interbody FusionStatus unknownNCT02808234Not applicable
• ReNu™ vs. Corticosteroids for the Treatment of Plantar FasciitisStatus unknownNCT02982226Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot UlcersCompletedNCT02880592Not applicable
• Affinity Prospective Diabetic Foot Trial Crossover GroupCompletedNCT03205436Not applicable
• A Prospective Study of NuCel® in Cervical Spine FusionTerminatedNCT02381067Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar SpineCompletedNCT02023372Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• NuTech Affinity™ for the Treatment of Chondral DefectsStatus unknownNCT02837484Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• ReNu™ Marrow Stimulation AugmentationTerminatedNCT03036878Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• An Investigation of ReNu™ Knee Injection in Patients With OsteoarthritisCompletedNCT02318511Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• NuShield in Surgical Peroneal Tendon RepairStatus unknownNCT03828916Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted after NuTech Medical, Inc became part of Organogenesis

• ReNu™ Injection to Treat Hip Osteoarthritis StudyCompletedNCT03063099Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• The RESPOND RegistryCompletedNCT03286452
• NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot UlcersCompletedNCT02461641Not applicable

  Sponsor listed in the registry: NuTech Medical, Inc · First submitted before NuTech Medical, Inc became part of Organogenesis

• Pivotal Trial of Dermagraft(R) to Treat Venous Leg UlcersCompletedNCT00909870Phase 3
• Dermagraft(R) for the Treatment of Patients With Diabetic Foot UlcersCompletedNCT01181440Phase 3
• Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot UlcersCompletedNCT01181453Phase 3
• PuraPly™ Antimicrobial Wound Matrix and Wound ManagementCompletedNCT03070938
• Prospective PuraPly™ AM Case Series StudyCompletedNCT03070925
• A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg UlcersCompletedNCT01327937Phase 4
• Safety Study of Gintuit™ in Subjects Requiring Socket GraftingTerminatedNCT01929954Phase 1/2
• A Post-Marketing Clinical Study of Apligraf for Venous Leg UlcersWithdrawnNCT00648674Phase 4
• A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®Status unknownNCT02011724Phase 4
• Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site WoundsTerminatedNCT01292122Not applicable
• Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue RegenerationCompletedNCT00587834Phase 3
• A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached GingivaCompletedNCT01547962Not applicable
• A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root CoverageTerminatedNCT00679081Phase 1/2
• A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised KeloidsCompletedNCT00587587Phase 1/2
• Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)TerminatedNCT00587223Phase 3
• Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot UlcersTerminatedNCT00512538Phase 3